WASHINGTON, D.C. - Although the defendants waived their right to respond, the U.S. Supreme Court on May 2 requested that defendants in a metoclopramide drug injury case file responses to a plaintiff's petition arguing that her design defect claim is not preempted by federal law (Julie Demahy v. Schwarz Pharma, Inc., et al., No. 12-1093, 5th Cir.; See 11/1/12, Page 4)....(read more)Image may be NSFW.
Clik here to view.
Clik here to view.
